Opinion statement Carcinoid is a rare neuroendocrine tumor that typically originates in the
gastrointestinal tract and can result in a constellation of symptoms, mediated by vasoactive …

Aim: Elevated serotonin in patients with neuroendocrine tumors (NETs) may impact heart
failure incidence but a quantitative relationship has not been established. Materials & …

Objective: This retrospective study evaluated physician practice patterns in the medical
management of patients with neuroendocrine tumors (NETs) treated with octreotide LAR …

Background Carcinoid heart disease (HD) is a rare form of valvular heart disease, the
features of which have not been fully described by cardiac computed tomography (CT) …

OBJECTIVE To evaluate the effects of resection of hepatic carcinoid metastases on
progression and prognosis of carcinoid heart disease. PATIENTS AND METHODS From our …

Abstract Background/Aims: Carcinoid heart disease (CHD), a complication of
neuroendocrine tumors (NETs), is characterized by right heart fibrotic lesions. Though …

The extent of heart disease and its relationship to the serotonin metabolite 5-
hydroxyindoleacetic acid (5-HIAA), was studied with M-mode, 2D and Doppler …

Carcinoid disease is caused by neuroendocrine tumors, most often located in the gut, and
leads in approximately 20% of cases to specific, severe heart disease, most prominently …

Patients with stage IV carcinoid tumors may benefit from more aggressive surgical
management and new treatment modalities. The growing body of knowledge regarding …

Carcinoid heart disease is a rare disease, and its prevalence is uncertain. The aim of the
present prospective study was to assess the prevalence of carcinoid heart disease using …